GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Syntara Ltd (ASX:SNT) » Definitions » 5-Year Yield-on-Cost %

Syntara (ASX:SNT) 5-Year Yield-on-Cost % : 0.00 (As of May. 17, 2024)


View and export this data going back to 2003. Start your Free Trial

What is Syntara 5-Year Yield-on-Cost %?

Syntara's yield on cost for the quarter that ended in Dec. 2023 was 0.00.


The historical rank and industry rank for Syntara's 5-Year Yield-on-Cost % or its related term are showing as below:



ASX:SNT's 5-Year Yield-on-Cost % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.08
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

Competitive Comparison of Syntara's 5-Year Yield-on-Cost %

For the Drug Manufacturers - Specialty & Generic subindustry, Syntara's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syntara's 5-Year Yield-on-Cost % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Syntara's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where Syntara's 5-Year Yield-on-Cost % falls into.



Syntara 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of Syntara is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5

Syntara  (ASX:SNT) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


Syntara 5-Year Yield-on-Cost % Related Terms

Thank you for viewing the detailed overview of Syntara's 5-Year Yield-on-Cost % provided by GuruFocus.com. Please click on the following links to see related term pages.


Syntara (ASX:SNT) Business Description

Traded in Other Exchanges
Address
20 Rodborough Road, Locked Bag 5015, Frenchs Forest, Sydney, NSW, AUS, 2086
Syntara Ltd Formerly Pharmaxis Ltd is an Australia based pharmaceutical research company engaged in the research, development, and commercialization of human healthcare products for the treatment and management of fibrotic and inflammatory diseases. The firm's research efforts are focused on discovering drugs to treat inflammatory and fibrotic diseases such as NASH, pulmonary fibrosis, kidney and liver fibrosis and cancer from its amine oxidase inhibitor chemistry platform. Its product pipeline also includes Orbital and ASM8. The operating segments are Mannitol respiratory business and New Drug Development. It generates maximum revenue from Mannitol respiratory business segment.